Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Celanese Says Mark Rohr Assumed Chairman And CEO Roles - Quick Facts

RELATED NEWS
Trade CE now with 

Celanese Corp. (CE: Quote) said Mark Rohr has assumed the roles of chairman and chief executive officer. He will be based at Celanese's corporate headquarters in Dallas, Texas.

Rohr was named by the Celanese Board of Directors in November 2011 to succeed David Weidman, who officially retired April 2, 2012.

Prior to assuming his new roles, Rohr visited Celanese sites and customers around the world including Asia, Europe and the Middle East. He will continue engaging with customers and other key stakeholders through aggressive outreach including a corporate blog, mobile applications and new website to be introduced later this year.

Rohr, a member of Celanese's Board of Directors since 2007, earlier held the positions of chief executive officer and chairman of Albemarle Corp., as well as executive chairman of its Board.

Click here to receive FREE breaking news email alerts for Celanese Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks came under pressure in early trading on Friday and remained firmly in the red throughout the remainder of the trading session. With the losses on the day, the S&P 500 pulled back well off yesterday's record closing high. President Barack Obama is meeting with presidents from Central American nations on Friday as the U.S. struggles to deal with a surge of unaccompanied children across the southern border. Despite calls from some leading conservatives, the results of a new CNN/ORC International poll released Friday showed that a vast majority of Americans do not believe that President Barack Obama should be impeached and removed from office.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.